Zacks Industry Outlook Highlights UnitedHealth, Humana and Centene
Zacks Investment Ideas Feature Highlights: FedEx, Casey's General Stores and Centene
CMS Proposes 4.33% Increase for Medicare Advantage Plans
Centene (NYSE:CNC) Shareholders Have Endured a 22% Loss From Investing in the Stock Three Years Ago
Express News | Centene Corporation Names First President Over Individual Coverage Health Reimbursement Arrangements (Ichra) Business
Press Release: Centene Corporation Names First President Over Individual Coverage Health Reimbursement Arrangements (ICHRA) Business
Unusual Options Activity: BP, TPR and Others Attract Market Bets, BP V/OI Ratio Reaches 156.3
EST Jan 7th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Compelling Reasons for Investors to Hold on to Centene Stock
Centene Corporation (CNC): Among the Cheap Healthcare Stocks to Buy Heading Into 2025
Buckle up! Goldman Sachs: Market optimism is nearing its peak, Bullish on two defensive Sectors.
①Goldman Sachs advises investors to take more "defensive measures" as Wall Street's optimism about the USA economy and stock market approaches historical highs. ②Goldman Sachs' model is bullish on the performance of defensive stocks such as utilities and Medical Care.
Will Weakness in Centene Corporation's (NYSE:CNC) Stock Prove Temporary Given Strong Fundamentals?
Centene Options Spot-On: On December 20th, 232.71K Contracts Were Traded, With 348.29K Open Interest
On December 20th ET, $Centene(CNC.US)$ had active options trading, with a total trading volume of 232.71K options for the day, of which put options accounted for 54.57% of the total transactions,
Baird Maintains Centene(CNC.US) With Hold Rating, Raises Target Price to $71
(CNC) - Analyzing Centene's Short Interest
Centene Corp Director Thomas Greco Buys $1.02 Million in Stock
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Baird Adjusts Centene Price Target to $71 From $66, Maintains Neutral Rating
Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years
Elevance Downgraded at Morgan Stanley on Medicaid Headwinds